J&J Units File Fourth Patent Suit Over Opsumit Generic

By Daniel Wilson · October 27, 2026, 2:25 PM AEST

Two units of U.S. pharmaceutical giant Johnson & Johnson have hit Australian generic drugmaker Lupin AU with a patent infringement suit in the Federal Court over Lupin's generic version of blood...

To view the full article, register now.